newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates

$207.3 Million in Cash and Cash Equivalents at June 30, 2024.Company in Advanced Discussions to Resolve SEC Investigation. $40 Million Estimated Loss Contingency Recorded in Q2 for Resolution.Conference Webcast Scheduled